You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
創勝集團(06628.HK)與華檢醫療達成戰略合作 擬探索首創腫瘤療法代幣化融資
創勝集團-B(06628.HK)宣佈與華檢醫療控股(01931.HK)及其兩間子公司簽署不具法律約束力的戰略合作協議,根據協議,雙方將探索通過以太坊區塊鏈發行真實世界資產代幣,爲六項「同類首創」及「同類最佳」的腫瘤創新療法項目籌集臨牀前及臨牀開發資金。 公司表示,此將爲生物醫藥領域首例代幣化融資模式,若發行成功,所得資金將用於加速多項創新腫瘤抗體項目研發,應用於TST005、TST003、TST786、TST105、TST106及TST013六個創新腫瘤項目。公司創始人、董事長兼首席執行官錢雪明表示,非常高興能夠率先探索這一開創性的區塊鏈融資方式,加速推進公司創新的早期腫瘤產品管線的開發。
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account